Literature DB >> 18663378

Apaf-1-deficient fog mouse cell apoptosis involves hypo-polarization of the mitochondrial inner membrane, ATP depletion and citrate accumulation.

Iyoko Katoh1, Shingo Sato, Nahoko Fukunishi, Hiroki Yoshida, Takasuke Imai, Shun-Ichi Kurata.   

Abstract

To explore how the intrinsic apoptosis pathway is controlled in the spontaneous fog (forebrain overgrowth) mutant mice with an Apaf1 splicing deficiency, we examined spleen and bone marrow cells from Apaf1(+/+) (+/+) and Apaf1(fog/fog) (fog/fog) mice for initiator caspase-9 activation by cellular stresses. When the mitochondrial inner membrane potential (Deltapsim) was disrupted by staurosporine, +/+ cells but not fog/fog cells activated caspase-9 to cause apoptosis, indicating the lack of apoptosome (apoptosis protease activating factor 1 (Apaf-1)/cytochrome c/(d)ATP/procaspase-9) function in fog/fog cells. However, when a marginal ( approximately 20%) decrease in Deltapsim was caused by hydrogen peroxide (0.1 mM), peroxynitritedonor 3-morpholinosydnonimine (0.1 mM) and UV-C irradiation (20 J/m(2)), both +/+ and fog/fog cells triggered procaspase-9 auto-processing and its downstream cascade activation. Supporting our previous results, procaspase-9 pre-existing in the mitochondria induced its auto-processing before the cytosolic caspase activation regardless of the genotypes. Cellular ATP concentration significantly decreased under the hypoactive Deltapsim condition. Furthermore, we detected accumulation of citrate, a kosmotrope known to facilitate procaspase-9 dimerization, probably due to a feedback control of the Krebs cycle by the electron transfer system. Thus, mitochondrial in situ caspase-9 activation may be caused by the major metabolic reactions in response to physiological stresses, which may represent a mode of Apaf-1-independent apoptosis hypothesized from recent genetic studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18663378     DOI: 10.1038/cr.2008.87

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  7 in total

1.  Intravitreal injection of mitochondrial DNA induces cell damage and retinal dysfunction in rats.

Authors:  Yue Guo; Dekang Gan; Fangyuan Hu; Yun Cheng; Jian Yu; Boya Lei; Qinmeng Shu; Ruiping Gu; Gezhi Xu
Journal:  Biol Res       Date:  2022-06-03       Impact factor: 7.634

2.  Chapter 24 Quantification, localization, and tissue specificities of mouse mitochondrial reactive oxygen species production.

Authors:  Aaron M Gusdon; Jing Chen; Tatyana V Votyakova; Clayton E Mathews
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

3.  The impairment of HCCS leads to MLS syndrome by activating a non-canonical cell death pathway in the brain and eyes.

Authors:  Alessia Indrieri; Ivan Conte; Giancarlo Chesi; Alessia Romano; Jade Quartararo; Rosarita Tatè; Daniele Ghezzi; Massimo Zeviani; Paola Goffrini; Ileana Ferrero; Paola Bovolenta; Brunella Franco
Journal:  EMBO Mol Med       Date:  2013-01-22       Impact factor: 12.137

4.  An epistatic effect of apaf-1 and caspase-9 on chlamydial infection.

Authors:  Mohd Akhlakur Rahman; Mutsunori Shirai; Md Abdul Aziz; Rie Ushirokita; Sayuri Kubota; Harumi Suzuki; Yoshinao Azuma
Journal:  Apoptosis       Date:  2015-10       Impact factor: 4.677

5.  Antimicrobial Peptide TP4 Induces ROS-Mediated Necrosis by Triggering Mitochondrial Dysfunction in Wild-Type and Mutant p53 Glioblastoma Cells.

Authors:  Bor-Chyuan Su; Chieh-Yu Pan; Jyh-Yih Chen
Journal:  Cancers (Basel)       Date:  2019-02-01       Impact factor: 6.639

Review 6.  Clinical Applications and Anticancer Effects of Antimicrobial Peptides: From Bench to Bedside.

Authors:  Ameneh Jafari; Amirhesam Babajani; Ramin Sarrami Forooshani; Mohsen Yazdani; Mostafa Rezaei-Tavirani
Journal:  Front Oncol       Date:  2022-02-23       Impact factor: 6.244

Review 7.  Cell apoptosis, autophagy and necroptosis in osteosarcoma treatment.

Authors:  Jing Li; Zuozhang Yang; Yi Li; Junfeng Xia; Dongqi Li; Huiling Li; Mingyan Ren; Yedan Liao; Shunling Yu; Yanjin Chen; Yihao Yang; Ya Zhang
Journal:  Oncotarget       Date:  2016-07-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.